Description
Description
Acrotac 25 contains Acitretin, which belongs to a class of medications known as Retinoids. Acitretin is effective in treating severe skin problems in which skin has become thick and scaly. These skin disorders include psoriasis and keratosis follicularis. The oral form of this retinoid drug makes your skin grow more normally and improves the skin’s condition.
Because of adverse reactions associated with its use, Acitretin should be reserved for patients with the health conditions listed above when these are unresponsive to or intolerant of standard therapy. The oral medication should only be prescribed by physicians who are experienced in using retinoids and understand the risk associated with Acrotac treatment.
Product Description
Acrotac 25 mg should not be used in pregnancy. It is highly teratogenic and must not be used in females who are pregnant or can become pregnant. The retinoid formulation is also contraindicated in females childbearing potential unless strict contraceptive measures are used four weeks before, during, and for at least three years following treatment discontinuation. Acitretin is known to cause a very high percentage of severe congenital disabilities. The risk is even high if the medicine is taken before or during pregnancy or within three years after the last dose, independent of previous treatment duration. After that, the doctor should assess the risks and desirability of continuing effective contraception. An Acitretin formulation should not be given to patients with known hypersensitivity to Acrotac, other retinoids, vitamin A, or any of the other ingredients. Research studies indicate that the retinoid formulation is excreted in breast milk. Therefore, nursing mothers should not receive this medication because of the potential for serious side effects in nursing infants. Women are instructed to not feed their babies for at least three years following discontinuation of Acitretin. Patients are advised to avoid alcohol or limit consumption during treatment and for two months after cessation of treatment. The retinoid drug is also contraindicated in patients with impaired hepatic function, renal disorder, chronic abnormally elevated blood lipid levels, hypervitaminosis A. An increased risk of hepatitis has been reported from the combined use of Acitretin and methotrexate.
Side Effects
Very common side effects of Acrotac 25 mg include dry skin, peeling of the skin, inflammation of the nasal mucosa, the sensation of burning skin, inflammatory skin changes, hair loss, the sensation of sticky skin, fragile nails, inflammation of the eye, feeling cold, swelling and pain in the area around your nails, etc. Using a good quality moisturizer or an emollient from the start of treatment can help you deal with dry skin issues.
How to Use
Always take Acrotac 25 mg the same way your doctor has told you. Check with your doctor if you have any doubts related to the use of this medication. Take the capsule at mealtime, preferably with milk. Swallow each capsule whole; do not open or chew the capsule. In general, the dose depends on the severity of the condition; therefore, it varies from one patient to another. Your doctor will decide the right dose for you.
Most patients are taking this retinoid formulation experience a relapse after discontinuing therapy. The use of Acitretin in children is not recommended. In elderly patients, the effects of ageing might be expected to increase some risks associated with Acrotac tablets.
For adults and elderly patients, doctors generally prescribe a 25 mg dose once a day. After 2 to 4 weeks of regular treatment, your doctor may increase or decrease your dose. Usually, patients take this oral retinoid drug for up to three months. However, your doctor may decide the exact duration of the treatment.
2 reviews for Acrotac 25mg Tablet
There are no reviews yet.